Trial Details
COMPLETEDBasic Information
| Clinical ID | c1275 |
|---|---|
| Identifier | NCT02497469 |
| Trial Title | An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Vedolizumab|DRUG: Adalimumab placebo|DRUG: Adalimumab|DRUG: Vedolizumab placebo |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Mobile |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2015-06-29 |
|---|---|
| Primary Completion Date | 2018-09-26 |
| Completion Date | 2019-01-18 |